| Income Statement |
| Operating Expenses | 55.12M |
|
| Research and Development Expense | 2.14M |
| Selling, General and Administrative Expense | 49.94M |
| Operating Income | -55.11M |
| Interest Expense | 79.25M |
| Net Income | -136.41M |
| Net Income Common Stock | -136.41M |
| Net Income Common Stock (USD) | -136.41M |
| Consolidated Income | -195.04M |
| Net Income to Non-Controlling Interests | -58.63M |
| Earnings per Basic Share | -0.51 |
| Earnings per Basic Share (USD) | -0.51 |
| Earnings per Diluted Share | -0.51 |
| Earning Before Interest & Taxes (EBIT) | -57.16M |
| Earning Before Interest & Taxes (USD) | -57.16M |
| Weighted Average Shares | 264.91M |
| Weighted Average Shares Diluted | 264.91M |
| Balance Sheet |
| Cash and Equivalents | 465.06M |
| Cash and Equivalents (USD) | 465.06M |
| Current Assets | 487.52M |
| Property, Plant & Equipment Net | 11.80B |
| Total Assets | 13.23B |
| Debt Current | 1.29M |
| Total Debt | 9.47B |
| Current Liabilities | 1.21B |
| Debt Non-Current | 9.47B |
| Total Liabilities | 10.87B |
| Accumulated Retained Earnings (Deficit) | -896.36M |
| Shareholders Equity | -30.71M |
| Shareholders Equity (USD) | -30.71M |
| Assets Non-Current | 12.74B |
| Total Debt (USD) | 9.47B |
| Liabilities Non-Current | 9.66B |
| Trade and Non-Trade Payables | 298.12M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.47M |
| Net Cash Flow from Financing | 1.05B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -242.02M |
| Capital Expenditure | -1.18B |
| Issuance (Purchase) of Equity Shares | 248.65M |
| Issuance (Repayment) of Debt Securities | 796.84M |
| Net Cash Flow from Investing | -1.18B |
| Net Cash Flow from Operations | -110.83M |
| Share Based Compensation | 5.45M |